Dr. Alai Goñi Ramirez on 20-Year Prostate Brachytherapy Outcomes & HDR vs. LDR Insights | ESTRO 2025 скачать в хорошем качестве

Dr. Alai Goñi Ramirez on 20-Year Prostate Brachytherapy Outcomes & HDR vs. LDR Insights | ESTRO 2025

In this special ESTRO 2025 interview, Dr. Alai Goñi Ramirez, radiation oncologist from San Sebastián, Spain, shares key findings from two decades of clinical experience in prostate brachytherapy. He discusses new data comparing HDR vs. LDR boosts, their long-term efficacy and toxicity, and the evolving role of androgen deprivation therapy (ADT). ✅ Highlights from the interview: ✔️ 20-year oncologic and toxicity outcomes: HDR vs. LDR as EBRT boost ✔️ Why short-course ADT may worsen GU outcomes in LDR patients ✔️ Technical shift: From CT-guided to TRUS-guided HDR, and real-time intraoperative LDR ✔️ The pressing need for stronger brachytherapy data to stand alongside SBRT About ESTRO 2025 ESTRO 2025 is the leading global event for radiation oncology professionals, hosted by the European Society for Radiotherapy and Oncology (ESTRO). This congress, held from May 2 to 6, 2025, at the Messe Wien Exhibition & Congress Center in Vienna, Austria, brings together experts from around the world to showcase cutting-edge research, discuss the latest advancements in radiotherapy, and explore future trends in oncology. #ESTRO2025 #ProstateCancer #Brachytherapy #HDR #LDR #RadiationOncology #SBRT SUBSCRIBE to get the latest #oncodaily    / @oncodailytv   Visit the OncoDaily Website : https://oncodaily.com Like OncoDaily on LinkedIn:   / oncodaily   Like OncoDaily on X (Twitter): https://x.com/oncodaily Follow OncoDaily on Instagram:   / oncodailynews   Follow OncoDaily on TikTok:   / oncodaily   Like OncoDaily on Facebook:   / oncodaily   SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter About OncoDaily OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”